In celebration of International Women's Day on 8 March, the BIA is delighted to bring you the first transatlantic Women in Biotech event, which they are running in partnership with the US-based organisation Women In Bio.
With their charity partner of the year, Ovarian Cancer Action, they are supporting Ovarian Cancer Awareness month at this Women in Biotech event. Cary Wakefield, CEO of Ovarian Cancer Action, will join them to give a few words at the start of the event. Additionally, they will be donating £10 per ticket sold for the event to Ovarian Cancer Action.
Whilst VCs in life sciences continue to put management teams that are ‘proven’ or known to them in place rather than backing diverse ones, later investment rounds will demand a broader, more diverse set of thinking to which companies need to adapt in order to attract more mature capital.
These challenges will be discussed with a panel representing a range of different investment stages – from both investor and leadership perspectives - taking in points of view from both sides of the Atlantic and encouraging an interactive discussion around best practice and how we can affect change, asking “how do we encourage investors to back female led/founded companies and diverse leadership teams from company inception?”.
Join up for the inaugural transatlantic Women in Biotech - extend your networks globally, catch up with familiar faces, and help us to make a difference.
Using an interactive virtual platform, everyone will be able to move from virtual table to table similar to at an in-person event. Bring your favourite drink (as best suits your time of day) and join us for this fantastic event with engaging online networking.
Please contact firstname.lastname@example.org if you have any questions or problems registering for the event.
16:00 GMT / 11:00 EST / 08:00 PST - Event platform opens
16:30 GMT / 11:30 EST / 08:30 PST - Welcome and introductions
Jane Wall, Director of Business Development and Membership Services, BIA
Sally Shorthose, Partner, Bird & Bird
Lisa Iadicicco, Chief Executive, Women In Bio
Cary Wakefield, CEO, Ovarian Cancer Action
16:45 GMT / 11:45 EST / 08:45 PST - Panel discussion and Q&A
Chair: Karl Simpson, CEO, Liftstream
Ros Deegan, CEO, OMass Therapeutics
Jackie Grant, Principal, Abingworth
Julie Grant, General Partner, Canaan
Annalisa Jenkins, NED
Uciane Scarlett, Principal,Oxford Sciences Innovation
17:45 GMT / 12:45 EST / 09:45 PST - Closing remarks
17:50 GMT / 12:50 EST / 09:50 PST - Networking at the virtual tables
19:00 GMT / 14:00 EST / 11:00 PST - Event closes